Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lingxian Granules for Acute Gouty Arthritis (damp-heat toxin pattern) Phase II Trial
CTR20255158Phase 2Active
- Sponsor
- Yusen New Drug
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lingxian Granules in gout, sponsored by Yusen New Drug. Started Feb 2026; status: active.
02
Drugs
Lingxian Granules
03
Conditions
gout
Beyond the preview
Go deeper on CTR20255158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255158.